Non disponible en dehors du Royaume-Uni et de l'Irlande
Biochem/physiol Actions
Selective I1 imidazoline receptor agonist.
Features and Benefits
This compound was developed by Servier. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This compound is featured on the Imidazoline Binding Sites page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Packaging
5 mg in glass bottle
25 mg in poly bottle
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :